Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interracial Study of Irinotecan PK in Colorectal Cancer
NCT00006103Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jul 2000
- Primary completion
- Apr 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of irinotecan in colorectal cancer (CRC), sponsored by Cancer and Leukemia Group B. Started Jul 2000; status: completed.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00006103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006103.